RA Capital Management, L.P. 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
RA Capital Management, L.P. | 3,206,271 7.100% |
122,713 (+3.98%) |
Filing |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
RA Capital Management, L.P. | 3,083,558 9.990% |
8 (+0.00%) |
Filing |
| 2023-12-29 4:30 pm Purchase |
2023-12-19 | 13G | UroGen Pharma Ltd. URGN |
RA Capital Management, L.P. | 3,083,550 9.990% |
3,083,550 (New Position) |
Filing |